Clinical trial
D-cycloserine for Major Depressive Disorder
NCT00408031 · Herzog Hospital, Other · Completed
Key facts
| NCT number | NCT00408031 |
|---|---|
| Title | D-cycloserine for Major Depressive Disorder |
| Official title | N-methyl-D-aspartate Receptor (NMDAR)-Based Pharmacotherapy With D-cycloserine for Treatment-resistant Major Depressive Disorder |
| Lead sponsor | Herzog Hospital, Other |
| Collaborators | National Alliance for Research on Schizophrenia and Depression |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Drug |
| Interventions | D-cycloserine |
| Enrollment | 26 |
| Start date | Jan 1, 2007 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Dec 5, 2006 |
| Last update posted | Aug 3, 2012 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: